Depression, comorbid anxiety disorders, and heart rate variability in physically healthy, unmedicated patients: implications for cardiovascular risk.

<h4>Context</h4>There is evidence that heart rate variability (HRV) is reduced in major depressive disorder (MDD), although there is debate about whether this effect is caused by medication or the disorder per se. MDD is associated with a two to fourfold increase in the risk of cardiac m...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Andrew H Kemp, Daniel S Quintana, Kim L Felmingham, Slade Matthews, Herbert F Jelinek
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2012
Materias:
R
Q
Acceso en línea:https://doaj.org/article/7ea770e0fd854edcae1f77283636b464
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:7ea770e0fd854edcae1f77283636b464
record_format dspace
spelling oai:doaj.org-article:7ea770e0fd854edcae1f77283636b4642021-11-18T07:28:14ZDepression, comorbid anxiety disorders, and heart rate variability in physically healthy, unmedicated patients: implications for cardiovascular risk.1932-620310.1371/journal.pone.0030777https://doaj.org/article/7ea770e0fd854edcae1f77283636b4642012-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/22355326/pdf/?tool=EBIhttps://doaj.org/toc/1932-6203<h4>Context</h4>There is evidence that heart rate variability (HRV) is reduced in major depressive disorder (MDD), although there is debate about whether this effect is caused by medication or the disorder per se. MDD is associated with a two to fourfold increase in the risk of cardiac mortality, and HRV is a robust predictor of cardiac mortality; determining a direct link between HRV and not only MDD, but common comorbid anxiety disorders, will point to psychiatric indicators for cardiovascular risk reduction.<h4>Objective</h4>To determine in physically healthy, unmedicated patients whether (1) HRV is reduced in MDD relative to controls, and (2) HRV reductions are driven by MDD alone, comorbid generalized anxiety disorder (GAD, characterized by anxious anticipation), or comorbid panic and posttraumatic stress disorders (PD/PTSD, characterized by anxious arousal).<h4>Design, setting, and patients</h4>A case-control study in 2006 and 2007 on 73 MDD patients, including 24 without anxiety comorbidity, 24 with GAD, and 14 with PD/PTSD. Seventy-three MDD and 94 healthy age- and sex-matched control participants were recruited from the general community. Participants had no history of drug addiction, alcoholism, brain injury, loss of consciousness, stroke, neurological disorder, or serious medical conditions. There were no significant differences between the four groups in age, gender, BMI, or alcohol use.<h4>Main outcome measures</h4>HRV was calculated from electrocardiography under a standardized short-term resting state condition.<h4>Results</h4>HRV was reduced in MDD relative to controls, an effect associated with a medium effect size. MDD participants with comorbid generalized anxiety disorder displayed the greatest reductions in HRV relative to controls, an effect associated with a large effect size.<h4>Conclusions</h4>Unmedicated, physically healthy MDD patients with and without comorbid anxiety had reduced HRV. Those with comorbid GAD showed the greatest reductions. Implications for cardiovascular risk reduction strategies in otherwise healthy patients with psychiatric illness are discussed.Andrew H KempDaniel S QuintanaKim L FelminghamSlade MatthewsHerbert F JelinekPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 7, Iss 2, p e30777 (2012)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Andrew H Kemp
Daniel S Quintana
Kim L Felmingham
Slade Matthews
Herbert F Jelinek
Depression, comorbid anxiety disorders, and heart rate variability in physically healthy, unmedicated patients: implications for cardiovascular risk.
description <h4>Context</h4>There is evidence that heart rate variability (HRV) is reduced in major depressive disorder (MDD), although there is debate about whether this effect is caused by medication or the disorder per se. MDD is associated with a two to fourfold increase in the risk of cardiac mortality, and HRV is a robust predictor of cardiac mortality; determining a direct link between HRV and not only MDD, but common comorbid anxiety disorders, will point to psychiatric indicators for cardiovascular risk reduction.<h4>Objective</h4>To determine in physically healthy, unmedicated patients whether (1) HRV is reduced in MDD relative to controls, and (2) HRV reductions are driven by MDD alone, comorbid generalized anxiety disorder (GAD, characterized by anxious anticipation), or comorbid panic and posttraumatic stress disorders (PD/PTSD, characterized by anxious arousal).<h4>Design, setting, and patients</h4>A case-control study in 2006 and 2007 on 73 MDD patients, including 24 without anxiety comorbidity, 24 with GAD, and 14 with PD/PTSD. Seventy-three MDD and 94 healthy age- and sex-matched control participants were recruited from the general community. Participants had no history of drug addiction, alcoholism, brain injury, loss of consciousness, stroke, neurological disorder, or serious medical conditions. There were no significant differences between the four groups in age, gender, BMI, or alcohol use.<h4>Main outcome measures</h4>HRV was calculated from electrocardiography under a standardized short-term resting state condition.<h4>Results</h4>HRV was reduced in MDD relative to controls, an effect associated with a medium effect size. MDD participants with comorbid generalized anxiety disorder displayed the greatest reductions in HRV relative to controls, an effect associated with a large effect size.<h4>Conclusions</h4>Unmedicated, physically healthy MDD patients with and without comorbid anxiety had reduced HRV. Those with comorbid GAD showed the greatest reductions. Implications for cardiovascular risk reduction strategies in otherwise healthy patients with psychiatric illness are discussed.
format article
author Andrew H Kemp
Daniel S Quintana
Kim L Felmingham
Slade Matthews
Herbert F Jelinek
author_facet Andrew H Kemp
Daniel S Quintana
Kim L Felmingham
Slade Matthews
Herbert F Jelinek
author_sort Andrew H Kemp
title Depression, comorbid anxiety disorders, and heart rate variability in physically healthy, unmedicated patients: implications for cardiovascular risk.
title_short Depression, comorbid anxiety disorders, and heart rate variability in physically healthy, unmedicated patients: implications for cardiovascular risk.
title_full Depression, comorbid anxiety disorders, and heart rate variability in physically healthy, unmedicated patients: implications for cardiovascular risk.
title_fullStr Depression, comorbid anxiety disorders, and heart rate variability in physically healthy, unmedicated patients: implications for cardiovascular risk.
title_full_unstemmed Depression, comorbid anxiety disorders, and heart rate variability in physically healthy, unmedicated patients: implications for cardiovascular risk.
title_sort depression, comorbid anxiety disorders, and heart rate variability in physically healthy, unmedicated patients: implications for cardiovascular risk.
publisher Public Library of Science (PLoS)
publishDate 2012
url https://doaj.org/article/7ea770e0fd854edcae1f77283636b464
work_keys_str_mv AT andrewhkemp depressioncomorbidanxietydisordersandheartratevariabilityinphysicallyhealthyunmedicatedpatientsimplicationsforcardiovascularrisk
AT danielsquintana depressioncomorbidanxietydisordersandheartratevariabilityinphysicallyhealthyunmedicatedpatientsimplicationsforcardiovascularrisk
AT kimlfelmingham depressioncomorbidanxietydisordersandheartratevariabilityinphysicallyhealthyunmedicatedpatientsimplicationsforcardiovascularrisk
AT sladematthews depressioncomorbidanxietydisordersandheartratevariabilityinphysicallyhealthyunmedicatedpatientsimplicationsforcardiovascularrisk
AT herbertfjelinek depressioncomorbidanxietydisordersandheartratevariabilityinphysicallyhealthyunmedicatedpatientsimplicationsforcardiovascularrisk
_version_ 1718423419663417344